(PharmaNewsWire.Com, January 28, 2017 ) According to Publisher, the Global 3D Printed Medical Devices market is expected to grow from $0.77 billion in 2015 to reach $3.19 billion by 2022 with a CAGR of 22.6%. Huge investments in R&D and continuous technological advancements in 3D printing are the major factors driving the market. Furthermore, booming market for organ transplantation, increasing acceptance of 3D-printed implants and organs are some of the key factors fueling the market growth. However, stringent regulations on medical devices to get approvals and high costs of 3D-printed organs are expected to hinder the market.
North America is anticipated to hold the largest share in global market due to increased government financial support to enhance 3D printing applications in the healthcare industry, and establishment of research & training centers in this region. Asia Pacific is expected to witness huge growth due to increasing demand of organ transplantation in emerging countries such as China, Japan and India. However, high cost of 3D printing systems and lack of skilled professionals are limiting its demand in the Asian countries.
Some of the key players in global 3D printed medical devices market include 3D Systems Corporation, 3T RPD, Ltd., Arcam AB, Concept Laser GmbH, Envisiontec GmbH, Eos GmbH, Electro Optical Systems, Materialise NV, Prodways, Renishaw PLC, Stratasys Ltd
Optomec, Amedica Corporation, Oceanz, and Zortrax.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
